178 related articles for article (PubMed ID: 30831507)
1. Cytomegalovirus enterocolitis in a patient with dihydropyrimidine dehydrogenase deficiency after capecitabine treatment: A case report.
Inoue F; Yano T; Nakahara M; Okuda H; Amano H; Yonehara S; Noriyuki T
Int J Surg Case Rep; 2019; 56():55-58. PubMed ID: 30831507
[TBL] [Abstract][Full Text] [Related]
2. Severe adverse events due to dihydropyrimidine dehydrogenase deficiency in a Japanese patient with colon cancer taking capecitabine: a case report.
Tsutsui M; Yamamoto S; Yoshikawa Y; Nakanishi R; Takano K; Osumi K; Akatsu T; Yoneyama K; Nakagawa M; Kanai T
Int Cancer Conf J; 2018 Oct; 7(4):125-129. PubMed ID: 31149530
[TBL] [Abstract][Full Text] [Related]
3. [Dihydropyrimidine dehydrogenase deficiency causes severe adverse effects of capecitabine].
Inoue H; Sato Y; Shintani S; Tanabe H; Bamba H; Komai Y; Nakamura T; Imai T; Andou A
Nihon Shokakibyo Gakkai Zasshi; 2018; 115(3):290-298. PubMed ID: 29526981
[TBL] [Abstract][Full Text] [Related]
4. Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach.
Boisdron-Celle M; Capitain O; Faroux R; Borg C; Metges JP; Galais MP; Kaassis M; Bennouna J; Bouhier-Leporrier K; Francois E; Baumgaertner I; Guerin-Meyer V; Cojocarasu O; Roemer-Becuwe C; Stampfli C; Rosenfeld L; Lecompte T; Berger V; Morel A; Gamelin E
Semin Oncol; 2017 Feb; 44(1):13-23. PubMed ID: 28395758
[TBL] [Abstract][Full Text] [Related]
5. [Severe toxicity following capecitabine administration because of dihydropyrimidine deshydrogenase (DPD) deficiency].
Coursier S; Martelet S; Guillermet A; Emptoz J; Villier C; Bontemps H
Gastroenterol Clin Biol; 2010 Mar; 34(3):218-23. PubMed ID: 20219304
[TBL] [Abstract][Full Text] [Related]
6. [Dihydropyrimidine déhydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: Update and recommendations of the French GPCO-Unicancer and RNPGx networks].
Loriot MA; Ciccolini J; Thomas F; Barin-Le-Guellec C; Royer B; Milano G; Picard N; Becquemont L; Verstuyft C; Narjoz C; Schmitt A; Bobin-Dubigeon C; Harle A; Paci A; Poinsignon V; Quaranta S; Evrard A; Hennart B; Broly F; Fonrose X; Lafay-Chebassier C; Wozny AS; Masskouri F; Boyer JC; Etienne-Grimaldi MC
Bull Cancer; 2018 Apr; 105(4):397-407. PubMed ID: 29486921
[TBL] [Abstract][Full Text] [Related]
7. Severe toxicity of capecitabine in a patient with DPD deficiency after a safe FEC-100 experience: why we should test DPD deficiency in all patients before high-dose fluoropyrimidines.
Maillard M; Eche-Gass A; Ung M; Brice A; Marsili S; Montastruc M; Puisset F; Thomas F
Cancer Chemother Pharmacol; 2021 Apr; 87(4):579-583. PubMed ID: 33587160
[TBL] [Abstract][Full Text] [Related]
8. [A case in which dihydropyrimidine dehydrogenase deficiency was strongly suspected during adjuvant chemotherapy with capecitabine for colon cancer].
Toshima T; Kodera M; Yamashita Y; Oishi M; Seshimo K; Yamamura M; Kato H; Ikeda H; Mizuno K
Gan To Kagaku Ryoho; 2013 Nov; 40(11):1549-52. PubMed ID: 24231713
[TBL] [Abstract][Full Text] [Related]
9. Severe Gastrointestinal Disorder Due to Capecitabine Associated with Dihydropyrimidine Dehydrogenase Deficiency: A Case Report and Literature Review.
Hagiwara Y; Yamamoto Y; Inagaki Y; Tomisaki R; Tsuji M; Fukuda S; Fukuda S; Onoda T; Suzuki H; Niisato Y; Tange Y; Ikeda N; Yamada K; Kobayashi M; Akutsu D; Yamada T; Moriwaki T; Narasaka T; Suzuki H; Tsuchiya K
Intern Med; 2022 Aug; 61(16):2449-2455. PubMed ID: 35110482
[TBL] [Abstract][Full Text] [Related]
10. Capecitabine-based treatment of a patient with a novel DPYD genotype and complete dihydropyrimidine dehydrogenase deficiency.
Henricks LM; Siemerink EJM; Rosing H; Meijer J; Goorden SMI; Polstra AM; Zoetekouw L; Cats A; Schellens JHM; van Kuilenburg ABP
Int J Cancer; 2018 Jan; 142(2):424-430. PubMed ID: 28929491
[TBL] [Abstract][Full Text] [Related]
11. Unpredicted severe toxicity after 5-fluorouracil treatment due to dihydropyrimidine dehydrogenase deficiency.
Baek JH; Kim JG; Kim SN; Kim DH; Sohn SK; Hong YJ; Lee KB
Korean J Intern Med; 2006 Mar; 21(1):43-5. PubMed ID: 16646564
[TBL] [Abstract][Full Text] [Related]
12. DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY (DPD) IN GI MALIGNANCIES: EXPERIENCE OF 4-YEARS.
Saif MW; Syrigos K; Mehra R; Mattison LK; Diasio RB
Pak J Med Sci; 2007; 23(6):832-839. PubMed ID: 18846242
[TBL] [Abstract][Full Text] [Related]
13. [Severe toxicity after treatment with capecitabine and fluorouracil due to partial dihydropyrimidine dehydrogenase deficiency].
Hooiveld EA; van Kuilenburg AB; Haanen JB; Westermann AM
Ned Tijdschr Geneeskd; 2004 Mar; 148(13):626-8. PubMed ID: 15083629
[TBL] [Abstract][Full Text] [Related]
14. Is capecitabine safe in patients with gastrointestinal cancer and dihydropyrimidine dehydrogenase deficiency?
Saif MW; Diasio R
Clin Colorectal Cancer; 2006 Jan; 5(5):359-62. PubMed ID: 16512996
[TBL] [Abstract][Full Text] [Related]
15. Prolonged severe 5-fluorouracil-associated neurotoxicity in a patient with dihydropyrimidine dehydrogenase deficiency.
Shehata N; Pater A; Tang SC
Cancer Invest; 1999; 17(3):201-5. PubMed ID: 10099659
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of grade IV neutropenia after administration of 5-fluorouracil due to a dihydropyrimidine dehydrogenase deficiency: high prevalence of the IVS14+1g>a mutation.
Van Kuilenburg AB; Meinsma R; Zoetekouw L; Van Gennip AH
Int J Cancer; 2002 Sep; 101(3):253-8. PubMed ID: 12209976
[TBL] [Abstract][Full Text] [Related]
17. [Suspected dihydropyrimidine dehydrogenase deficiency in a patient receiving capecitabine as adjuvant chemotherapy after colon resection].
Nagai K; Okuda Y; Ohara Y; Yamamoto M
Gan To Kagaku Ryoho; 2015 Jan; 42(1):127-9. PubMed ID: 25596695
[TBL] [Abstract][Full Text] [Related]
18. The First Case of Severe Takotsubo Cardiomyopathy Associated with 5-Fluorouracil in a Patient with Abnormalities of Both Dihydropyrimidine Dehydrogenase (DPYD) and Thymidylate Synthase (TYMS) Genes.
Saif MW; Smith M; Maloney A
Cureus; 2016 Sep; 8(9):e783. PubMed ID: 27752409
[TBL] [Abstract][Full Text] [Related]
19. [Review of methods for determination of dihydropyrimidine dehydrogenase and possible application in screening previous chemotheraphy with 5-fluorouracil].
Ostapowicz A; Dołegowska B
Przegl Lek; 2012; 69(9):694-7. PubMed ID: 23401991
[TBL] [Abstract][Full Text] [Related]
20. High-resolution melting analysis of the common c.1905+1G>A mutation causing dihydropyrimidine dehydrogenase deficiency and lethal 5-fluorouracil toxicity.
Borràs E; Dotor E; Arcusa A; Gamundi MJ; Hernan I; de Sousa Dias M; Mañé B; Agúndez JA; Blanca M; Carballo M
Front Genet; 2012; 3():312. PubMed ID: 23335937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
